190 related articles for article (PubMed ID: 16585013)
21. Architecture and dynamics of the transcription factor network that regulates B-to-plasma cell differentiation.
Igarashi K; Ochiai K; Muto A
J Biochem; 2007 Jun; 141(6):783-9. PubMed ID: 17569706
[TBL] [Abstract][Full Text] [Related]
22. TCL1 in B-cell tumors retains its normal b-cell pattern of regulation and is a marker of differentiation stage.
Herling M; Patel KA; Hsi ED; Chang KC; Rassidakis GZ; Ford R; Jones D
Am J Surg Pathol; 2007 Jul; 31(7):1123-9. PubMed ID: 17592280
[TBL] [Abstract][Full Text] [Related]
23. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
[TBL] [Abstract][Full Text] [Related]
24. Plasma cell ontogeny defined by quantitative changes in blimp-1 expression.
Kallies A; Hasbold J; Tarlinton DM; Dietrich W; Corcoran LM; Hodgkin PD; Nutt SL
J Exp Med; 2004 Oct; 200(8):967-77. PubMed ID: 15492122
[TBL] [Abstract][Full Text] [Related]
25. Analysis of MUM1/IRF4 protein expression using tissue microarrays and immunohistochemistry.
Natkunam Y; Warnke RA; Montgomery K; Falini B; van De Rijn M
Mod Pathol; 2001 Jul; 14(7):686-94. PubMed ID: 11455001
[TBL] [Abstract][Full Text] [Related]
26. Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas.
Miles RR; Mankey CC; Seiler CE; Smith LB; Teruya-Feldstein J; Hsi ED; Elenitoba-Johnson KS; Lim MS
Hum Pathol; 2009 Dec; 40(12):1731-7. PubMed ID: 19716163
[TBL] [Abstract][Full Text] [Related]
27. B-cell non-Hodgkin lymphomas in Uganda: an immunohistochemical appraisal on tissue microarray.
Tumwine LK; Campidelli C; Righi S; Neda S; Byarugaba W; Pileri SA
Hum Pathol; 2008 Jun; 39(6):817-23. PubMed ID: 18436278
[TBL] [Abstract][Full Text] [Related]
28. Identification of uniquely expressed transcription factors in highly purified B-cell lymphoma samples.
Andréasson U; Edén P; Peterson C; Högerkorp CM; Jerkeman M; Andersen N; Berglund M; Sundström C; Rosenquist R; Borrebaeck CA; Ek S
Am J Hematol; 2010 Jun; 85(6):418-25. PubMed ID: 20513119
[TBL] [Abstract][Full Text] [Related]
29. The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas.
Cotta CV; Leventaki V; Atsaves V; Vidaki A; Schlette E; Jones D; Medeiros LJ; Rassidakis GZ
Cancer; 2008 Feb; 112(3):552-61. PubMed ID: 18085637
[TBL] [Abstract][Full Text] [Related]
30. FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes.
Takahashi H; Feuerhake F; Kutok JL; Monti S; Dal Cin P; Neuberg D; Aster JC; Shipp MA
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3265-71. PubMed ID: 16740746
[TBL] [Abstract][Full Text] [Related]
31. Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas.
Piccaluga PP; Califano A; Klein U; Agostinelli C; Bellosillo B; Gimeno E; Serrano S; Solè F; Zang Y; Falini B; Zinzani PL; Pileri SA
Haematologica; 2008 Jul; 93(7):1033-8. PubMed ID: 18492688
[TBL] [Abstract][Full Text] [Related]
32. T cells climb on board Blimp-1.
Jameson SC
Trends Immunol; 2006 Aug; 27(8):349-51. PubMed ID: 16807109
[TBL] [Abstract][Full Text] [Related]
33. DNA methylation profiling of transcription factor genes in normal lymphocyte development and lymphomas.
Ivascu C; Wasserkort R; Lesche R; Dong J; Stein H; Thiel A; Eckhardt F
Int J Biochem Cell Biol; 2007; 39(7-8):1523-38. PubMed ID: 17433759
[TBL] [Abstract][Full Text] [Related]
34. Extranodal lymphomas of the head and neck.
Vega F; Lin P; Medeiros LJ
Ann Diagn Pathol; 2005 Dec; 9(6):340-50. PubMed ID: 16308165
[TBL] [Abstract][Full Text] [Related]
35. Expression of inhibitor of apoptosis proteins in B-cell non-Hodgkin and Hodgkin lymphomas.
Akyurek N; Ren Y; Rassidakis GZ; Schlette EJ; Medeiros LJ
Cancer; 2006 Oct; 107(8):1844-51. PubMed ID: 16983704
[TBL] [Abstract][Full Text] [Related]
36. Focal adhesion kinase (FAK) expression in normal and neoplastic lymphoid tissues.
Ozkal S; Paterson JC; Tedoldi S; Hansmann ML; Kargi A; Manek S; Mason DY; Marafioti T
Pathol Res Pract; 2009; 205(11):781-8. PubMed ID: 19647948
[TBL] [Abstract][Full Text] [Related]
37. Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma.
Xia Y; Xu-Monette ZY; Tzankov A; Li X; Manyam GC; Murty V; Bhagat G; Zhang S; Pasqualucci L; Visco C; Dybkaer K; Chiu A; Orazi A; Zu Y; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Møller MB; Parsons BM; Winter JN; Piris MA; Westin J; Fowler N; Miranda RN; Ok CY; Li Y; Li J; Medeiros LJ; Young KH
Leukemia; 2017 Mar; 31(3):625-636. PubMed ID: 27568520
[TBL] [Abstract][Full Text] [Related]
38. Transcription of PRDM1, the master regulator for plasma cell differentiation, depends on an SP1/SP3/EGR-1 GC-box.
Mora-López F; Pedreño-Horrillo N; Delgado-Pérez L; Brieva JA; Campos-Caro A
Eur J Immunol; 2008 Aug; 38(8):2316-24. PubMed ID: 18604866
[TBL] [Abstract][Full Text] [Related]
39. Tissue inhibitor of metalloproteinase 1 (TIMP-1) promotes plasmablastic differentiation of a Burkitt lymphoma cell line: implications in the pathogenesis of plasmacytic/plasmablastic tumors.
Guedez L; Martinez A; Zhao S; Vivero A; Pittaluga S; Stetler-Stevenson M; Raffeld M; Stetler-Stevenson WG
Blood; 2005 Feb; 105(4):1660-8. PubMed ID: 15479729
[TBL] [Abstract][Full Text] [Related]
40. Diffuse large B-cell lymphoma with overexpression of cyclin e substantiates poor standard treatment response and inferior outcome.
Tzankov A; Gschwendtner A; Augustin F; Fiegl M; Obermann EC; Dirnhofer S; Went P
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2125-32. PubMed ID: 16609025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]